Australia markets closed

Microba Life Sciences Limited (MAP.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.3250+0.0100 (+3.17%)
At close: 03:03PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 113.17M
Enterprise value 83.92M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)15.70
Price/book (mrq)3.37
Enterprise value/revenue 17.90
Enterprise value/EBITDA -8.47

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-7.14%
S&P500 52-week change 3-8.38%
52-week high 30.4500
52-week low 30.1350
50-day moving average 30.3099
200-day moving average 30.2567

Share statistics

Avg vol (3-month) 3245.02k
Avg vol (10-day) 346.66k
Shares outstanding 5342.95M
Implied shares outstanding 6N/A
Float 8178.94M
% held by insiders 155.04%
% held by institutions 121.43%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)30 June 2022


Profit margin -244.64%
Operating margin (ttm)-347.05%

Management effectiveness

Return on assets (ttm)-35.09%
Return on equity (ttm)-47.33%

Income statement

Revenue (ttm)4.69M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)22.10%
Gross profit (ttm)2.37M
EBITDA -15.56M
Net income avi to common (ttm)-11.47M
Diluted EPS (ttm)-0.0550
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)30.79M
Total cash per share (mrq)0.11
Total debt (mrq)1.33M
Total debt/equity (mrq)3.95
Current ratio (mrq)6.80
Book value per share (mrq)0.12

Cash flow statement

Operating cash flow (ttm)-10.45M
Levered free cash flow (ttm)-10.46M